Onyx Trial Results Disappoint
Onyx Pharmaceuticals Inc. (ONXX) reported disappointing results for its skin cancer drug treatment sending the stock price plummeting $5.32 to close at $12.18.
posted by FC Market News at 11:02 AM
0 Comments:
Post a Comment
<< Home